Financial Performance - Operating revenue fell by 51.31% to CNY 34,305,703.24 year-on-year[5] - Net profit attributable to shareholders decreased by 89.31% to CNY 2,830,693.04 compared to the same period last year[5] - Basic earnings per share dropped by 89.26% to CNY 0.0071[5] - The company reported a significant decline in net profit due to reduced operating revenue and increased costs[5] - Total operating revenue for Q1 2020 was ¥34,305,703.24, a decrease of 51.3% compared to ¥70,454,860.94 in Q1 2019[30] - Net profit for Q1 2020 was ¥2,830,693.04, a decline of 89.2% from ¥26,308,541.27 in Q1 2019[31] - Operating profit for Q1 2020 was ¥2,537,849.33, down 91.5% from ¥29,788,442.90 in Q1 2019[31] - Other income for Q1 2020 was ¥696,413.61, a decrease from ¥1,558,786.00 in Q1 2019[31] Assets and Liabilities - Total assets decreased by 3.66% to CNY 1,243,956,919.75 compared to the end of the previous year[5] - The company's cash and cash equivalents decreased by 51.39% to CNY 24.85 million from CNY 51.12 million at the beginning of the period[15] - Accounts receivable decreased significantly by 89.58% to CNY 25.40 million from CNY 235.08 million[21] - Inventory increased by 20.00% to CNY 284.87 million from CNY 236.93 million[14] - Total liabilities decreased by 32.08% to CNY 8.50 million from CNY 12.54 million[14] - Total assets decreased from CNY 1,291,205,717.74 to CNY 1,243,956,919.75, a decline of approximately 3.65%[24] - Current liabilities increased from CNY 270,933,683.21 to CNY 318,308,190.68, an increase of about 17.54%[23] - Total liabilities rose from CNY 336,510,151.29 to CNY 384,408,940.08, reflecting an increase of around 14.23%[23] - The company's equity attributable to shareholders decreased from CNY 954,695,566.45 to CNY 859,547,979.67, a decline of about 9.95%[24] Cash Flow - Cash flow from operating activities improved by 56.28%, reaching a net cash flow of -21,235,073.15[5] - Cash inflow from operating activities in Q1 2020 was CNY 52,743,048.39, down 19.4% from CNY 65,461,677.50 in Q1 2019[37] - Cash outflow from operating activities in Q1 2020 totaled CNY 73,978,121.54, a decrease of 35.2% from CNY 114,030,995.75 in Q1 2019[37] - Net cash flow from operating activities was negative CNY 21,235,073.15, an improvement from negative CNY 48,569,318.25 in Q1 2019[37] - Cash flow from investing activities was negative CNY 4,816,814.87 in Q1 2020, compared to a positive cash flow of CNY 25,860,185.69 in Q1 2019[38] - The company reported a net cash outflow of CNY 26,271,804.68 in Q1 2020, compared to a net outflow of CNY 25,621,363.78 in Q1 2019[38] Shareholder Information - The total number of shareholders reached 12,027[11] - The largest shareholder, Xinjiang Hualing Industrial Trade Group, holds 19.86% of shares[11] Expenses - The company reported a 74.74% increase in selling expenses to CNY 1.33 million compared to CNY 0.76 million in the previous year[16] - Financial expenses surged by 1161.25% to CNY 0.57 million from CNY 0.04 million year-over-year[16] - The company experienced a 75.92% reduction in income tax expenses to CNY 0.83 million from CNY 3.44 million[17] - Management expenses for Q1 2020 were ¥15,373,837.32, an increase of 14.2% compared to ¥13,456,342.84 in Q1 2019[31] Other Financial Metrics - Non-recurring gains and losses totaled CNY 1,608,515.94[8] - Investment income decreased by 90.09% to CNY 0.05 million from CNY 0.53 million in the previous year[16] - Long-term equity investments remained relatively stable, with a slight increase from CNY 51,503,259.60 to CNY 51,529,307.19[22] - The company has a long-term equity investment valued at 51,503,259.60 RMB[44]
百花医药(600721) - 2020 Q1 - 季度财报